NCI Events

ODS Webinar Series

Webinar sessions focus on data sharing and usage topics including data event outcomes, data sharing and management policies, data sharing guidance, and data sharing processes, tools and resources.

Throughout the year, ODS will host speakers from the cancer research community, which highlight data sharing and usage in the community. If you have topic ideas please contact us at NCIOfficeofDataSharing@mail.nih.gov.

NCI/NIBIB Synthetic Biology and Cancer Series: Progress and Promise

The National Cancer Institute (NCI) and the National Institute for Biomedical Imaging and Bioengineering (NIBIB) collaboratively launched the Synthetic Biology and Cancer Program in 2021. The goal of the program was to support synthetic biology approaches for cancer research that would expand technology development, promote transdisciplinary partnerships, spur new efforts to advance mechanistic understanding of cancer, and create new possibilities for cancer prevention and management. After five years of progress, the teams will share their discoveries with the broader research community. The Synthetic Biology and Cancer: Progress and Promise Webinar Series invites you to learn about the exciting technical advances in synthetic biology and how they have accelerated cancer research, and explore future directions. The series will occur monthly from June to November 2026.

Workshop on Community Engagement to Build Trust in Science and Enhance Environmental Epidemiology Cancer Research

Convened by the National Cancer Institute (NCI), the one day virtual workshop brings together leaders in environmental epidemiology, cancer research, behavioral science, and community engagement to examine how community engagement can reduce cancer risk related to environmental exposures and strengthen trust in science.

Cancer and Alzheimer's Disease Intersection (CADIC) Forum

A growing body of research consistently demonstrates an inverse relationship between cancer and Alzheimer's disease, with each condition associated with reduced risk or delayed onset of the other. The CADIC Forum webinar series brings together investigators from the cancer and Alzheimer's disease research communities to understand the mechanisms underlying this association and uncover insights into novel therapeutic interventions for both diseases.

Translational Research in Clinical Oncology (TRACO)

TRACO is designed to provide an overview of general principles of cancer biology and treatment, epidemiology, genomics, precision medicine, mechanisms of resistance, use of preclinical models, and identification of novel molecular targets. Participants will have an unprecedented opportunity to learn new information, glimpse into future developments of translational research in clinical oncology and meet leaders in cancer research. The participation of NIH Postdoctoral and Clinical Fellows is encouraged.

Translating Biomolecular Condensates in Cancer: From Discovery to Clinical Application

The National Cancer Institute’s Division of Cancer Treatment and Diagnosis and Division of Cancer Biology are jointly hosting a hybrid workshop to explore how advances in biomolecular condensate biology can be translated into cancer biomarkers, therapeutic targets, and intervention strategies.

Childhood Cancer Data Initiative (CCDI) Annual Symposium

Join the Childhood Cancer Data Initiative (CCDI) Symposium on September 18, 2026, to reflect on our progress and shape what comes next in childhood cancer research. This hybrid event, offered both in person at the National Cancer Institute (NCI) Shady Grove Campus in Rockville, MD, and online, will highlight advances in data infrastructure, showcase AI-driven insights, and explore opportunities to accelerate discovery and improve outcomes for children, adolescents, and young adults.

CPTAC Scientific Symposium Public

The National Cancer Institute’s Office of Cancer Clinical Proteomics Research (OCCPR) and Clinical Proteomic Tumor Analysis Consortium (CPTAC) are pleased to announce the 2026 CPTAC Scientific Symposium. Join us on September 21, 2026 to learn about the most current advances in the field of cancer proteogenomics and cancer research by our CPTAC investigators. While this meeting is in-person for CPTAC consortium and NIH participants, only virtual option is available for public attendees.

Workshop on Understanding Plasticity and its Role Across the Cancer Continuum

The Workshop on Understanding Plasticity and its Role Across the Cancer Continuum” will be held in a hybrid format, with speakers participating in person and the public attending virtually.

2026 NCI Cohort Consortium Annual Meeting

The 2026 Annual Meeting of the NCI Cohort Consortium will be a hybrid event held on September 24 – 25, 2026. The meeting is sponsored by the Division of Cancer Control and Population Sciences (Epidemiology and Genomics Research Program) and the Division of Cancer Epidemiology and Genetics of the National Cancer Institute (NCI), with a goal to bring together consortium researchers to discuss emerging science, scientific progress of consortium projects and groups, gaps, and opportunities for collaboration across studies, and ideas for new scientific projects in the consortium.

Translational Advances in Cancer Prevention Agent Development (TACPAD) – 4th Biennial Virtual Meeting

Translational Advances in Cancer Prevention Agent Development (TACPAD) – 4th Biennial Virtual Meeting is sponsored by the Division of Cancer Prevention at the National Cancer Institute (NCI), NIH. This biennial meeting brings together leading basic, translational, and clinical researchers to advance the development of cancer prevention and interception strategies. The program highlights emerging immunoprevention and chemoprevention agents, innovative preclinical and clinical research, biomarker development, and prevention clinical trials while fostering collaboration and accelerating the translation of promising prevention concepts into clinical practice.

Fall 2026 NCI Early Drug Development

The NCI CTEP Early Drug Development Meeting is held annually to enhance communication between NCI and the network of ETCTN investigators that conduct CTEP-sponsored early phase clinical trials. The meeting is open to academic, government, and pharmaceutical clinical investigators and related health care personnel (e.g., nurses, statisticians, translational scientist, etc.) involved in CTEP funded oncology early drug development. The focus of the meeting is on prioritizing investigational agent selection and targeting, novel trial designs, and development and implementation of translational studies, as well as on new therapeutic and imaging modalities. The data presented at the meeting is considered a private communication, and the information should not be disseminated for public use.

Science-Based Non-Academic Careers

As fellows and staff scientists at the National Cancer Institute, many of you will be exploring and choosing from various science-based career options in the future. The Office of Training and Education (OTE) in the Center for Cancer Training (CCT) is hosting weekly workshops, September 16 to November 4, 2026, to help participants learn about the various career opportunities that lie outside of independent academic research. Given these may include unfamiliar roles outside of traditional bench science, we have guest speakers from various science-based backgrounds to provide information and insight that will help inform decisions about potential future endeavors. For details about the course schedule, invited speakers, and program contacts, please visit the SNAC website.

NCI Data Jamboree

The National Cancer Institute (NCI) invites you to participate in the 2026 NCI Data Jamboree: Enhancing Data Sharing and Utility to Advance Cancer Research on November 16-18 at the NIH Neuroscience Building in Rockville, Maryland. The overarching goal is to promote data sharing and use, facilitate interdisciplinary collaborations, and engage and expand the size and scientific diversity of the cancer research community.

Cancer Neuroscience and Symptoms Workshop

The Cancer Neuroscience and Symptoms Workshop is a two-day virtual workshop taking place on November 16 - 17, 2026. The workshop will provide a forum focused on the neuropathogenesis of cancer symptoms, with emphasis on three linked aims: address knowledge gaps, identify exploitable molecular targets, and develop intervention strategies for prevention and treatment of cancer symptoms and long-term sequelae.

DCEG/REB Radiation Epidemiology & Dosimetry Course

The Radiation Epidemiology and Dosimetry Course is conducted periodically by the Radiation Epidemiology Branch of the NCI Division of Cancer Epidemiology and Genetics (DCEG). This course is intended for people who are interested in learning about the health effects of radiation exposure (environmental, occupational, and medical)—particularly the relationship between ionizing radiation and cancer